Simultaneous Transcatheter Closure of a Ventricular Septal Defect and Pulmonary Valvuloplasty: A Case Report
Baraa Alghalyini1, Abdul Rehman Zia Zaidi1, Hadeel Khalid Bin Shuiel2
1Department of Family & Community Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Insights
Transcatheter interventions successfully treated complex congenital heart diseases (CHDs), including pulmonary valve stenosis (PVS) and ventricular septal defects (VSD). This minimally invasive approach offers a promising alternative to surgery, improving patient outcomes and quality of life.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pediatric Cardiology
Background:
- Congenital heart diseases (CHDs) are common birth defects impacting heart structure and function.
- Pulmonary valve stenosis (PVS) and ventricular septal defects (VSD) are prevalent CHDs requiring timely intervention.
- Transcatheter techniques offer minimally invasive alternatives to open-heart surgery for CHDs.
Observation:
- A 19-year-old male presented with complex CHDs requiring a tailored treatment strategy.
- The patient exhibited symptoms of significant cardiac compromise.
- A transcatheter approach was selected for intervention.
Findings:
- Successful closure of a ventricular septal defect (VSD) using an Amplatzer device.
- Resolution of pulmonary valve stenosis (PVS) through balloon valvuloplasty.
- The procedures were performed without complications, leading to a notable recovery.
Implications:
- Transcatheter interventions play a crucial role in managing complex CHDs.
- Minimally invasive approaches are shifting the paradigm in cardiac care.
- Further research is needed on the long-term efficacy of these techniques across diverse populations.
Abstract:
BACKGROUND Congenital heart diseases (CHDs) are the most common form of birth defects, affecting the structure and function of neonatal hearts. Pulmonary valve stenosis (PVS) and ventricular septal defects (VSD) are 2 of the more prevalent forms, both of which can lead to significant morbidity if left untreated. The emergence of transcatheter techniques has revolutionized the therapeutic landscape, presenting minimally invasive yet effective alternatives to open-heart surgery and significantly reducing associated patient morbidity and recovery time. CASE REPORT The presented case details the management of a 19-year-old man with complex CHDs, highlighting the nuanced decision-making process that led to a transcatheter approach. The patient's clinical presentation, marked by symptoms reflective of significant cardiac compromise, demanded a tailored approach that utilized the latest advancements in non-surgical intervention. The successful closure of the VSD with an Amplatzer device and the resolution of PVS via balloon valvuloplasty were achieved without complications, showcasing the potential of these techniques in managing similar cases. The post-intervention period was marked by a noteworthy recovery, confirming the procedural efficacy and enhancing the patient's quality of life. CONCLUSIONS The favorable outcome of this case highlights the pivotal role of transcatheter interventions in treating complex CHDs and suggests a shift towards less invasive approaches in cardiac care. This case contributes valuable insights to the existing body of evidence, reinforcing the potential of transcatheter techniques to become the preferred treatment modality. With promising immediate and short-term results, these techniques highlight the need for continued research into their long-term efficacy and application across diverse patient demographics.
